• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤:当前和未来治疗方法的综述。

Osteosarcoma: a review of current and future therapeutic approaches.

机构信息

Anhui Chest Hospital, 397 Jixi Road, Hefei, 230022, China.

Materials Genome Institute, Shanghai University, Shanghai, 201800, China.

出版信息

Biomed Eng Online. 2021 Mar 2;20(1):24. doi: 10.1186/s12938-021-00860-0.

DOI:10.1186/s12938-021-00860-0
PMID:33653371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7923306/
Abstract

Osteosarcoma (OS) is the most common primary bone malignancy that affects children and young adults. OS is characterized by a high degree of malignancy, strong invasiveness, rapid disease progression, and extremely high mortality rate; it is considered as a serious threat to the human health globally. The incidence of OS is common in the metaphysis of long tubular bones, but rare in the spine, pelvis, and sacrum areas; moreover, majority of the OS patients present with only a single lesion. OS has a bimodal distribution pattern, that is, its incidence peaks in the second decade of life and in late adulthood. We examine historical and current literature to present a succinct review of OS. In this review, we have discussed the types, clinical diagnosis, and modern and future treatment methods of OS. The purpose of this article is to inspire new ideas to develop more effective therapeutic options.

摘要

骨肉瘤(OS)是一种常见的原发性骨恶性肿瘤,主要影响儿童和青少年。OS 具有高度恶性、强侵袭性、疾病进展迅速和极高死亡率的特点,被认为是全球范围内对人类健康的严重威胁。OS 的发病率常见于长管状骨的干骺端,但在脊柱、骨盆和骶骨区域较为罕见;此外,大多数 OS 患者仅表现为单个病灶。OS 呈双峰分布模式,即其发病率在生命的第二个十年和成年晚期达到高峰。我们查阅了历史和当前的文献,对 OS 进行了简明的综述。在本综述中,我们讨论了 OS 的类型、临床诊断以及现代和未来的治疗方法。本文的目的是激发新的思路,开发更有效的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e219/7923306/4210bc558da3/12938_2021_860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e219/7923306/4210bc558da3/12938_2021_860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e219/7923306/4210bc558da3/12938_2021_860_Fig1_HTML.jpg

相似文献

1
Osteosarcoma: a review of current and future therapeutic approaches.骨肉瘤:当前和未来治疗方法的综述。
Biomed Eng Online. 2021 Mar 2;20(1):24. doi: 10.1186/s12938-021-00860-0.
2
Osteosarcoma.骨肉瘤
Cancer Treat Res. 2014;162:65-92. doi: 10.1007/978-3-319-07323-1_4.
3
Osteosarcoma treatment: state of the art.骨肉瘤治疗:最新进展
Cancer Metastasis Rev. 2009 Jun;28(1-2):247-63. doi: 10.1007/s10555-009-9186-7.
4
PET tracers for osteosarcoma.骨肉瘤的正电子发射断层显像(PET)示踪剂
J Nucl Med. 2004 Aug;45(8):1424; author reply 1424-5.
5
Applied Nanotechnology and Nanoscience in Orthopedic Oncology.应用纳米技术与纳米科学在骨肿瘤学中的应用
Orthopedics. 2016 Sep 1;39(5):280-6. doi: 10.3928/01477447-20160823-03.
6
PET imaging of osteosarcoma.骨肉瘤的正电子发射断层显像
J Nucl Med. 2003 Jun;44(6):930-42.
7
Pediatric Malignant Bone Tumors: A Review and Update on Current Challenges, and Emerging Drug Targets.小儿恶性骨肿瘤:当前挑战及新兴药物靶点的综述与更新
Curr Probl Pediatr Adolesc Health Care. 2016 Jul;46(7):213-228. doi: 10.1016/j.cppeds.2016.04.002. Epub 2016 Jun 2.
8
[Osteosarcoma of the pelvisTwo case reports and review of the literature].[骨盆骨肉瘤:两例报告并文献复习]
Unfallchirurg. 2004 Jul;107(7):625-32. doi: 10.1007/s00113-004-0753-7.
9
[Bone scintigraphy in two cases of primary vertebral osteosarcoma in adults].[两例成人原发性椎体骨肉瘤的骨闪烁显像]
Rev Esp Med Nucl. 2001 Jun;20(4):299-304. doi: 10.1016/s0212-6982(01)71962-3.
10
Osteosarcoma subtypes: Magnetic resonance and quantitative diffusion weighted imaging criteria.骨肉瘤亚型:磁共振成像及定量扩散加权成像标准
J Egypt Natl Canc Inst. 2018 Mar;30(1):39-44. doi: 10.1016/j.jnci.2018.01.006. Epub 2018 Feb 21.

引用本文的文献

1
Autophagy Protease ATG4D Facilitates Proliferation and Malignancy of Osteosarcoma Cells.自噬蛋白酶ATG4D促进骨肉瘤细胞的增殖和恶性发展。
FASEB J. 2025 Sep 15;39(17):e70990. doi: 10.1096/fj.202501321RR.
2
Linking Environmental Hazards to Osteosarcoma Development: A Comprehensive Review.将环境危害与骨肉瘤发展相联系:一项综合综述
Cancer Manag Res. 2025 Aug 21;17:1725-1739. doi: 10.2147/CMAR.S542371. eCollection 2025.
3
Molecular Crosstalk Between RUNX2 and HIF-1α in Osteosarcoma: Implications for Angiogenesis, Metastasis, and Therapy Resistance.

本文引用的文献

1
Osteosarcoma.骨肉瘤。
Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28352. doi: 10.1002/pbc.28352. Epub 2020 Aug 11.
2
Guideline for Limb-Salvage Treatment of Osteosarcoma.保肢治疗骨肉瘤的指南。
Orthop Surg. 2020 Aug;12(4):1021-1029. doi: 10.1111/os.12702. Epub 2020 Jul 6.
3
Recent advances of drug delivery nanocarriers in osteosarcoma treatment.药物递送纳米载体在骨肉瘤治疗中的最新进展
骨肉瘤中RUNX2与HIF-1α之间的分子串扰:对血管生成、转移和治疗抗性的影响
Int J Mol Sci. 2025 Aug 7;26(15):7642. doi: 10.3390/ijms26157642.
4
Cluster of differentiation 133 (CD133) and C-X-C chemokine receptor 4 (CXCR4) associated with the incidence of metastasis in osteosarcoma patients.分化簇133(CD133)和C-X-C趋化因子受体4(CXCR4)与骨肉瘤患者的转移发生率相关。
Eur J Orthop Surg Traumatol. 2025 Jul 23;35(1):318. doi: 10.1007/s00590-025-04434-x.
5
Red-emitting fluorescent probes based on sulfur-substituted barbituric acid derivatives: synthesis, properties and biomedical applications.基于硫取代巴比妥酸衍生物的红色荧光探针:合成、性质及生物医学应用
RSC Adv. 2025 Jul 21;15(32):25894-25901. doi: 10.1039/d5ra02821c.
6
Urolithin A suppressed osteosarcoma cell migration and invasion via targeting MMPs and AKT1.尿石素A通过靶向基质金属蛋白酶(MMPs)和蛋白激酶B1(AKT1)抑制骨肉瘤细胞的迁移和侵袭。
Sci Rep. 2025 Jul 17;15(1):25941. doi: 10.1038/s41598-025-11804-2.
7
[Reconstruction of bone defects after resection of osteosarcoma in children with artificial hemi-knee prosthesis].[人工半膝关节假体修复儿童骨肉瘤切除术后骨缺损]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Jul 15;39(7):824-830. doi: 10.7507/1002-1892.202503035.
8
Whole‑exome evolutionary profiling of osteosarcoma uncovers metastasis‑related driver mutations and generates an independently validated predictive classifier.骨肉瘤的全外显子组进化分析揭示了与转移相关的驱动突变,并生成了一个经独立验证的预测分类器。
J Transl Med. 2025 Jul 7;23(1):746. doi: 10.1186/s12967-025-06796-6.
9
Comparison of Differentially Expressed Genes in Human and Canine Osteosarcoma.人类与犬骨肉瘤中差异表达基因的比较
Life (Basel). 2025 Jun 12;15(6):951. doi: 10.3390/life15060951.
10
Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment.材料驱动的疗法:彻底改变骨肉瘤治疗的功能性纳米材料设计范例
J Funct Biomater. 2025 Jun 5;16(6):213. doi: 10.3390/jfb16060213.
J Cancer. 2020 Jan 1;11(1):69-82. doi: 10.7150/jca.36588. eCollection 2020.
4
Limb salvage surgery with joint preservation for malignant humeral bone tumors: operative procedures and clinical application.保留关节的恶性肱骨骨肿瘤保肢手术:手术步骤及临床应用
BMC Surg. 2019 May 30;19(1):57. doi: 10.1186/s12893-019-0519-3.
5
Current and Emerging Targets in Immunotherapy for Osteosarcoma.骨肉瘤免疫治疗的当前及新出现的靶点
J Oncol. 2019 Jan 1;2019:7035045. doi: 10.1155/2019/7035045. eCollection 2019.
6
The Significance of a "Close" Margin in Extremity Sarcoma: A Systematic Review.肢体肉瘤“切缘阳性”的意义:一项系统评价
Iowa Orthop J. 2018;38:123-130.
7
Understanding osteosarcomas.了解骨肉瘤。
JAAPA. 2018 Aug;31(8):15-19. doi: 10.1097/01.JAA.0000541477.24116.8d.
8
Immunotherapy for osteosarcoma: Where do we go from here?骨肉瘤的免疫治疗:我们的路在何方?
Pediatr Blood Cancer. 2018 Sep;65(9):e27227. doi: 10.1002/pbc.27227. Epub 2018 Jun 19.
9
Osteosarcoma: a comprehensive review.骨肉瘤:一篇综述
SICOT J. 2018;4:12. doi: 10.1051/sicotj/2017028. Epub 2018 Apr 9.
10
Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment.老年人原发性骨肉瘤再探:诊断与治疗的当前概念。
Curr Oncol Rep. 2018 Feb 28;20(2):13. doi: 10.1007/s11912-018-0658-1.